Here are Boston-area biotechs pursuing Parkinson’s treatments

Here are Boston-area biotechs pursuing Parkinson’s treatments
The continued need for new Parkinson's disease treatments drew attention this week, with one local gene therapy biotech striking a $165 million collaboration deal, while another companies' drug was re ... read more
Source: Bing NewsPublished on 2019-01-31